Determinants of Oligonucleotide Selectivity of APOBEC3B
Overview
Medical Informatics
Authors
Affiliations
APOBEC3B (A3B) is a prominent source of mutation in many cancers. To date, it has been difficult to capture the native protein-DNA interactions that confer A3B's substrate specificity by crystallography due to the highly dynamic nature of wild-type A3B active site. We use computational tools to restore a recent crystal structure of a DNA-bound A3B C-terminal domain mutant construct to its wild type sequence, and run molecular dynamics simulations to study its substrate recognition mechanisms. Analysis of these simulations reveal dynamics of the native A3Bctd-oligonucleotide interactions, including the experimentally inaccessible loop 1-oligonucleotide interactions. A second series of simulations in which the target cytosine nucleotide was computationally mutated from a deoxyribose to a ribose show a change in sugar ring pucker, leading to a rearrangement of the binding site and revealing a potential intermediate in the binding pathway. Finally, apo simulations of A3B, starting from the DNA-bound open state, experience a rapid and consistent closure of the binding site, reaching conformations incompatible with substrate binding. This study reveals a more realistic and dynamic view of the wild type A3B binding site and provides novel insights for structure-guided design efforts for A3B.
Regulatory interactions between APOBEC3B N- and C-terminal domains.
Braza M, Demir O, Ahn S, Morris C, Calvo-Tusell C, McGuire K bioRxiv. 2024; .
PMID: 39713448 PMC: 11661193. DOI: 10.1101/2024.12.11.628032.
Development of Allosteric Small Molecule APOBEC3B Inhibitors from Screening.
Jones K, Demir O, Wyllie M, Grillo M, Morris C, Hirakis S bioRxiv. 2024; .
PMID: 38712210 PMC: 11071470. DOI: 10.1101/2024.04.25.591187.
Papini C, Wang Z, Kudalkar S, Schrank T, Tang S, Sasaki T iScience. 2022; 25(10):105077.
PMID: 36164654 PMC: 9508485. DOI: 10.1016/j.isci.2022.105077.
Cheng A, Moraes S, Shaban N, Fanunza E, Bierle C, Southern P Viruses. 2021; 13(3).
PMID: 33671095 PMC: 7998176. DOI: 10.3390/v13030390.
Shi K, Demir O, Carpenter M, Banerjee S, Harki D, Amaro R FASEB Bioadv. 2020; 2(1):49-58.
PMID: 32123856 PMC: 6996314. DOI: 10.1096/fba.2019-00068.